Healius (ASX:HLS) ROCE % : -3.53% (As of Dec. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Healius ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Healius's annualized ROCE % for the quarter that ended in Dec. 2024 was -3.53%.

Healius ROCE % Historical Data

The historical data trend for Healius's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius ROCE % Chart

Healius Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROCE %

Get a 7-Day Free Trial

1.41

6.62

13.13

-11.31

-22.94

Healius Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial															-1.69	-20.96	-45.81	0.27	-3.53

Healius ROCE % Calculation

Healius's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	-620.1	/	( ( (3653.2 - 629.6)	+	(2982.8 - 600.3) )	/ 2 )
	=	-620.1	/	( (3023.6	+	2382.5)	/ 2 )
	=	-620.1	/	2703.05
	=	-22.94 %

Healius's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	-82	/	( ( (2982.8 - 600.3)	+	(3067 - 804.2) )	/ 2 )
	=	-82	/	( ( 2382.5	+	2262.8 )	/ 2 )
	=	-82	/	2322.65
	=	-3.53 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

Healius (ASX:HLS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Healius ROCE % Related Terms

Thank you for viewing the detailed overview of Healius's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Healius Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (ASX:HLS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

PHCRF:USA PGZ:Germany

Address

161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000

Website

https://www.healius.com.au

Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.

Healius Headlines

No Headlines